Day: April 1, 2021

8. veebruaril 2021 edastas Finantsinspektsioon (FSA) Admiral Markets AS-ile otsuse, mille kohaselt määrati ettevõttele trahv. Finantsinspektsiooni sõnul ei olnud Admiral Markets AS pärast toornafta hindade märkimisväärset langust aprillis 2020 käitunud täielikult vastavalt väärtpaberituru seadusele. Admiral Markets AS ei nõustunud Finantsinspektsiooni otsusega ning kinnitas, et on alati tegutsenud oma klientide huvides. Ettevõte oli veendunud, et hoolimata Finantsinspektsiooni otsuses avaldatud hinnangutest toimiti vastavalt regulatiivsele õiguslikule raamistikule ebatavaliste asjaolude korral. Sellest tulenevalt esitas Admiral Markets AS 23.02.2021 kaebuse Harju Maakohtusse otsuse vaidlustamiseks.  Harju Maakohtu 31.03. 2021 määrusega rahuldati Admiral Markets AS kaebus ning tühistati Finantsinspektsiooni otsus täies ulatuses.   Harju...

GAITHERSBURG, Md., April 01, 2021 (GLOBE NEWSWIRE) — Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, reported clinical data today on its NasoShield intranasal anthrax vaccine candidate. The Phase 1b trial evaluated the safety and immunogenicity of one and two-dose regimens of NasoShield in healthy volunteers. The clinical trial was conducted with support from the Biomedical Advanced Research and Development Authority (BARDA). The trial enrolled 42 healthy subjects who received intranasally administered NasoShield or saline placebo and were then monitored for 6 months post-dosing. The primary endpoint was the safety and tolerability of NasoShield. The primary immunogenicity readouts included the serum binding antibody to protective antigen and anthrax toxin blocking antibody responses at 28- and 56-days...

BRANFORD, Conn., April 01, 2021 (GLOBE NEWSWIRE) — Sachem Capital Corp. (NYSE American: SACH) announced today that its board of directors authorized and declared a quarterly dividend of $0.12 per share to be paid to shareholders of record as of the close of trading on the NYSE American on April 12, 2021. The dividend will be payable on April 16, 2021. John Villano, CPA, Chief Executive Officer of Sachem Capital Corp., stated, “We are pleased to declare the issuance of this dividend, which reflects the strength of our business operations and robust loan pipeline despite the COVID-19 pandemic. We continue to grow our loan portfolio in our traditional markets, as well as new markets such as Florida, while protecting and preserving capital in a manner that provides for attractive risk-adjusted returns to our shareholders over the long...

GREENWICH, Conn., April 01, 2021 (GLOBE NEWSWIRE) —  XPO Logistics, Inc. (NYSE: XPO), a leading global provider of supply chain solutions, has been recognized by Intel Corporation with a Supplier Achievement Award (SAA) for its COVID-19 response in 2020. Intel selects its SAA recipients annually based on an exceptional commitment to quality, performance and a collaborative approach to innovation. Malcolm Wilson, chief executive officer of XPO Logistics – Europe, said, “We’re proud to receive this prestigious award from Intel, as it recognizes one of our greatest strengths — the high performance of our people and technology working together to deliver on our commitments. We thank Intel for this recognition.” Intel’s Supplier Achievement Awards are part of its Supplier Continuous Quality Improvement program, which recognizes best-in-class...

Fiscal Year 2020 Revenue of US$6.7 million, down 28% compared to Fiscal Year 2019 Positive Cash Flow from Operations Implemented Annualized Cost Reductions of US$1.1 million to Position for the Recovery Paycheck Protection Program 1 & 2 Funding of US$1.2 millionLOS ANGELES, April 01, 2021 (GLOBE NEWSWIRE) — Omni-Lite Industries Canada Inc. (the “Company” or “Omni-Lite”; TSXV: OML) today reported results for the year ending December 31, 2020. Full financial results are available at sedar.com. Fourth Quarter Fiscal 2020 Results Revenue for the fourth quarter of fiscal 2021 was approximately US$1.3 million, a decrease of approximately 40% as compared to the fourth quarter of fiscal 2019. The decrease in revenue was due principally to the impact of the COVID-19 pandemic on the commercial aerospace and other markets....

MALVERN, Pa., April 01, 2021 (GLOBE NEWSWIRE) — Baudax Bio, Inc. (Nasdaq: BXRX), a pharmaceutical company focused on therapeutics for acute care settings, today announced that the Compensation Committee of Baudax Bio’s Board of Directors approved an inducement grant of stock options to purchase an aggregate of 7,500 shares of Baudax Bio’s common stock and restricted stock units covering 2,000 shares of Baudax Bio’s common stock in connection with one newly-hired employee with a grant date of March 31, 2021. The equity award was granted pursuant to the Nasdaq Rule 5635(c)(4) inducement grant exception as a component of the individual’s employment compensation and was granted as an inducement material to his acceptance of employment with Baudax Bio. The options have an exercise price equal to $1.29 per share, the closing price of...

CHICAGO and VANCOUVER, British Columbia, April 01, 2021 (GLOBE NEWSWIRE) — Green Thumb Industries Inc. (Green Thumb) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of Rise™ Dispensaries, today announced that its executive team will participate in the following conferences in April 2021: ROTH Virtual Golden Cannabis Day, April 7, 2021: Founder and CEO Ben Kovler will participate on a brand-focused panel at 4:00 pm ET and management will participate in one-on-one meetings. Stifel Canada Cross Sector Insight Conference, April 21, 2021: Management will participate in one-on-one meetings. About Green Thumb Industries: Green Thumb Industries Inc. (“Green Thumb”), a national cannabis consumer packaged goods company and retailer, promotes well-being through the power of cannabis while giving...

Expands Food Systems platform with stabilizing and texturizing solutions broadening the Company’s customer base Brings label-friendly ingredients and innovative solutions that align with the latest consumer trendsWESTCHESTER, Ill., April 01, 2021 (GLOBE NEWSWIRE) — Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions to the food and beverage industry, announced today that it has acquired KaTech, a privately held company headquartered in Lübeck, Germany that provides advanced texture and stabilization solutions to the food and beverage industry. The acquisition complements Ingredion’s existing specialty ingredient portfolio by expanding its Food Systems platform with a comprehensive suite of innovative solutions that assist food and beverage manufacturers with product formulation, ingredient functionality...

LEXINGTON, Mass. and AMSTERDAM, April 01, 2021 (GLOBE NEWSWIRE) — uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced its participation in the following upcoming virtual investor and scientific conferences:Virtual Guggenheim Healthcare Talks│2021 Genomic Medicines & Rare Disease, April 1, 2021Members of uniQure’s management team will participate in virtual one-on-one investor meetings throughout the day on Thursday, April 1. Matt Kapusta, chief executive officer, will participate on a panel discussion entitled, “The Low-Hanging Fruit in Gene Therapy Might Be Hard to Reach – Challenges for Hemophilia A and B” on Thursday, April 1 from 10:00 to 10:50 a.m. ET. The live webcast of the fireside chat can be accessed through the...

BARRIE, Ontario, April 01, 2021 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, today announced STADA Arzneimittel AG (STADA), a leading European consumer health and generics company, and MediPharm Labs, under an exclusive, turnkey supply agreement, have commenced sales in Germany. As a result, patients in Germany are now able to access GMP-certified quality medical cannabis from STADA through local pharmacies under the brand – CannabiSTADA, distributed through STADAPHARM, a direct subsidiary of STADA. “This is the beginning of a meaningful long-term partnership dedicated to bringing the unique benefits of GMP-certified medical cannabis to patients in Europe,”...